88 related articles for article (PubMed ID: 21299244)
1. Potent farnesyltransferase inhibitors with 1,4-diazepane scaffolds as novel destabilizing microtubule agents in hormone-resistant prostate cancer.
Wlodarczyk N; Le Broc-Ryckewaert D; Gilleron P; Lemoine A; Farce A; Chavatte P; Dubois J; Pommery N; Hénichart JP; Furman C; Millet R
J Med Chem; 2011 Mar; 54(5):1178-90. PubMed ID: 21299244
[TBL] [Abstract][Full Text] [Related]
2. New arylthioindoles: potent inhibitors of tubulin polymerization. 2. Structure-activity relationships and molecular modeling studies.
De Martino G; Edler MC; La Regina G; Coluccia A; Barbera MC; Barrow D; Nicholson RI; Chiosis G; Brancale A; Hamel E; Artico M; Silvestri R
J Med Chem; 2006 Feb; 49(3):947-54. PubMed ID: 16451061
[TBL] [Abstract][Full Text] [Related]
3. 4- and 5-aroylindoles as novel classes of potent antitubulin agents.
Liou JP; Wu CY; Hsieh HP; Chang CY; Chen CM; Kuo CC; Chang JY
J Med Chem; 2007 Sep; 50(18):4548-52. PubMed ID: 17685504
[TBL] [Abstract][Full Text] [Related]
4. 7-Aroyl-aminoindoline-1-sulfonamides as a novel class of potent antitubulin agents.
Chang JY; Hsieh HP; Chang CY; Hsu KS; Chiang YF; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Nov; 49(23):6656-9. PubMed ID: 17154496
[TBL] [Abstract][Full Text] [Related]
5. 2-amino and 2'-aminocombretastatin derivatives as potent antimitotic agents.
Chang JY; Yang MF; Chang CY; Chen CM; Kuo CC; Liou JP
J Med Chem; 2006 Oct; 49(21):6412-5. PubMed ID: 17034147
[TBL] [Abstract][Full Text] [Related]
6. Synthetic analogues of the microtubule-stabilizing sponge alkaloid ceratamine A are more active than the natural product.
Nodwell M; Zimmerman C; Roberge M; Andersen RJ
J Med Chem; 2010 Nov; 53(21):7843-51. PubMed ID: 20945907
[TBL] [Abstract][Full Text] [Related]
7. Identification of CKD-516: a potent tubulin polymerization inhibitor with marked antitumor activity against murine and human solid tumors.
Lee J; Kim SJ; Choi H; Kim YH; Lim IT; Yang HM; Lee CS; Kang HR; Ahn SK; Moon SK; Kim DH; Lee S; Choi NS; Lee KJ
J Med Chem; 2010 Sep; 53(17):6337-54. PubMed ID: 20690624
[TBL] [Abstract][Full Text] [Related]
8. 2-(6-aryl-3(Z)-hexen-1,5-diynyl)anilines as a new class of potent antitubulin agents.
Lo YH; Lin CC; Lin CF; Lin YT; Duh TH; Hong YR; Yang SH; Lin SR; Yang SC; Chang LS; Wu MJ
J Med Chem; 2008 May; 51(9):2682-8. PubMed ID: 18386884
[TBL] [Abstract][Full Text] [Related]
9. [4-(imidazol-1-yl)thiazol-2-yl]phenylamines. A novel class of highly potent colchicine site binding tubulin inhibitors: synthesis and cytotoxic activity on selected human cancer cell lines.
Mahboobi S; Sellmer A; Höcher H; Eichhorn E; Bär T; Schmidt M; Maier T; Stadlwieser JF; Beckers TL
J Med Chem; 2006 Sep; 49(19):5769-76. PubMed ID: 16970401
[TBL] [Abstract][Full Text] [Related]
10. Indolizine-phenothiazine hybrids as the first dual inhibitors of tubulin polymerization and farnesyltransferase with synergistic antitumor activity.
Moise IM; Bîcu E; Farce A; Dubois J; Ghinet A
Bioorg Chem; 2020 Oct; 103():104184. PubMed ID: 32891861
[TBL] [Abstract][Full Text] [Related]
11. 10-(2-oxo-2-phenylethylidene)-10H-anthracen-9-ones as highly active antimicrotubule agents: synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Prinz H; Schmidt P; Böhm KJ; Baasner S; Müller K; Unger E; Gerlach M; Günther EG
J Med Chem; 2009 Mar; 52(5):1284-94. PubMed ID: 19220018
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and evaluation of azetidinone analogues of combretastatin A-4 as tubulin targeting agents.
O'Boyle NM; Carr M; Greene LM; Bergin O; Nathwani SM; McCabe T; Lloyd DG; Zisterer DM; Meegan MJ
J Med Chem; 2010 Dec; 53(24):8569-84. PubMed ID: 21080725
[TBL] [Abstract][Full Text] [Related]
13. Indolobenzazepin-7-ones and 6-, 8-, and 9-membered ring derivatives as tubulin polymerization inhibitors: synthesis and structure--activity relationship studies.
Putey A; Popowycz F; Do QT; Bernard P; Talapatra SK; Kozielski F; Galmarini CM; Joseph B
J Med Chem; 2009 Oct; 52(19):5916-25. PubMed ID: 19743863
[TBL] [Abstract][Full Text] [Related]
14. New farnesyltransferase inhibitors in the phenothiazine series.
Belei D; Dumea C; Samson A; Farce A; Dubois J; Bîcu E; Ghinet A
Bioorg Med Chem Lett; 2012 Jul; 22(14):4517-22. PubMed ID: 22738631
[TBL] [Abstract][Full Text] [Related]
15. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
Romagnoli R; Baraldi PG; Carrion MD; Cara CL; Cruz-Lopez O; Preti D; Tolomeo M; Grimaudo S; Di Cristina A; Zonta N; Balzarini J; Brancale A; Sarkar T; Hamel E
Bioorg Med Chem; 2008 May; 16(10):5367-76. PubMed ID: 18440234
[TBL] [Abstract][Full Text] [Related]
16. Potent antitubulin tumor cell cytotoxins based on 3-aroyl indazoles.
Duan JX; Cai X; Meng F; Lan L; Hart C; Matteucci M
J Med Chem; 2007 Mar; 50(5):1001-6. PubMed ID: 17286393
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
Romagnoli R; Baraldi PG; Pavani MG; Tabrizi MA; Preti D; Fruttarolo F; Piccagli L; Jung MK; Hamel E; Borgatti M; Gambari R
J Med Chem; 2006 Jun; 49(13):3906-15. PubMed ID: 16789746
[TBL] [Abstract][Full Text] [Related]
18. Structure-based virtual screening of novel tubulin inhibitors and their characterization as anti-mitotic agents.
Kim ND; Park ES; Kim YH; Moon SK; Lee SS; Ahn SK; Yu DY; No KT; Kim KH
Bioorg Med Chem; 2010 Oct; 18(19):7092-100. PubMed ID: 20810285
[TBL] [Abstract][Full Text] [Related]
19. Sulfonate derivatives of naphtho[2,3-b]thiophen-4(9H)-one and 9(10H)-anthracenone as highly active antimicrotubule agents. Synthesis, antiproliferative activity, and inhibition of tubulin polymerization.
Zuse A; Schmidt P; Baasner S; Böhm KJ; Müller K; Gerlach M; Günther EG; Unger E; Prinz H
J Med Chem; 2007 Nov; 50(24):6059-66. PubMed ID: 17973361
[TBL] [Abstract][Full Text] [Related]
20. Steroid hormone receptors as targets for the therapy of breast and prostate cancer--recent advances, mechanisms of resistance, and new approaches.
Hoffmann J; Sommer A
J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):191-200. PubMed ID: 15860262
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
